Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis.

耐受性 医学 荟萃分析 分裂情感障碍 精神科 精神分裂症(面向对象编程) 随机对照试验 抗精神病药 内科学 安慰剂
作者
A Cipriani
出处
期刊:The Lancet [Elsevier BV]
卷期号:399 (10327): 824-836 被引量:2
标识
DOI:10.1016/s0140-6736(21)01997-8
摘要

Schizophrenia is a common, severe, and usually chronic disorder. Maintenance treatment with antipsychotic drugs can prevent relapse but also causes side-effects. We aimed to compare the efficacy and tolerability of antipsychotics as maintenance treatment for non-treatment resistant patients with schizophrenia.In this systematic review and network meta-analysis, we searched, without language restrictions, the Cochrane Schizophrenia Group's specialised register between database inception and April 27, 2020, PubMed from April 1, 2020, to Jan 15, 2021, and the lists of included studies from related systematic reviews. We included randomised controlled trials (RCTs; ≥12 weeks of follow-up) that recruited adult participants with schizophrenia or schizoaffective disorder with stable symptoms who were treated with antipsychotics (monotherapy; oral or long-acting injectable) or placebo. We excluded RCTs of participants with specific comorbidities or treatment resistance. In duplicate, two authors independently selected eligible RCTs and extracted aggregate data. The primary outcome was the number of participants who relapsed and was analysed by random-effects, Bayesian network meta-analyses. The study was registered on PROSPERO, CRD42016049022.We identified 4157 references through our search, from which 501 references on 127 RCTs of 32 antipsychotics (comprising 18 152 participants) were included. 100 studies including 16 812 participants and 30 antipsychotics contributed to our network meta-analysis of the primary outcome. All antipsychotics had risk ratios (RRs) less than 1·00 when compared with placebo for relapse prevention and almost all had 95% credible intervals (CrIs) excluding no effect. RRs ranged from 0·20 (95% CrI 0·05-0·41) for paliperidone oral to 0·65 (0·16-1·14) for cariprazine oral (moderate-to-low confidence in estimates). Generally, we interpret that there was no clear evidence for the superiority of specific antipsychotics in terms of relapse prevention because most comparisons between antipsychotics included a probability of no difference.As we found no clear differences between antipsychotics for relapse prevention, we conclude that the choice of antipsychotic for maintenance treatment should be guided mainly by their tolerability.The German Ministry of Education and Research and Oxford Health Biomedical Research Centre.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
3秒前
蓬松小面包完成签到 ,获得积分20
4秒前
bkagyin应助大白采纳,获得10
4秒前
4秒前
量子星尘发布了新的文献求助10
5秒前
收集快乐发布了新的文献求助10
6秒前
bsf123完成签到,获得积分10
6秒前
7秒前
DeepLearning发布了新的文献求助10
9秒前
9秒前
科研通AI2S应助细辛采纳,获得10
9秒前
10秒前
10秒前
俭朴依白完成签到,获得积分10
10秒前
ElbingX完成签到,获得积分10
12秒前
暴躁小龙发布了新的文献求助10
13秒前
文档发布了新的文献求助10
14秒前
14秒前
严溯发布了新的文献求助10
15秒前
15秒前
17秒前
momo发布了新的文献求助10
17秒前
不可思宇完成签到,获得积分10
18秒前
18秒前
浩浩发布了新的文献求助10
19秒前
Philip发布了新的文献求助10
20秒前
21秒前
赘婿应助SherlockHe采纳,获得10
21秒前
橘子的角动量完成签到,获得积分10
22秒前
严溯完成签到,获得积分10
23秒前
24秒前
胡航航发布了新的文献求助20
24秒前
雨的痕迹发布了新的文献求助10
25秒前
AnnieSsy完成签到,获得积分10
25秒前
程程发布了新的文献求助10
26秒前
浩浩完成签到,获得积分10
27秒前
朴素的小霸王完成签到 ,获得积分10
29秒前
RESLR发布了新的文献求助20
31秒前
32秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989297
求助须知:如何正确求助?哪些是违规求助? 3531418
关于积分的说明 11253893
捐赠科研通 3270097
什么是DOI,文献DOI怎么找? 1804884
邀请新用户注册赠送积分活动 882087
科研通“疑难数据库(出版商)”最低求助积分说明 809158